Purple Biotech Ltd. Holds Annual Shareholder Meeting
Ticker: PPBT · Form: 6-K · Filed: Apr 22, 2025 · CIK: 1614744
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, agm
TL;DR
Purple Biotech held its AGM on 4/22, shareholders voted on key company matters.
AI Summary
Purple Biotech Ltd. announced the results of its Annual General Meeting of Shareholders held on April 22, 2025. The meeting took place at the company's offices in Rehovot, Israel. Specific resolutions voted on and their outcomes were detailed in the filing.
Why It Matters
Shareholder meetings are crucial for corporate governance, allowing investors to influence company direction and hold management accountable.
Risk Assessment
Risk Level: low — This filing is a routine report of a shareholder meeting and does not contain new financial or operational risks.
Key Players & Entities
- Purple Biotech Ltd. (company) — Filer and subject of the report
- April 22, 2025 (date) — Date of the Annual General Meeting
- Rehovot, Israel (location) — Location of the company's offices where the meeting was held
FAQ
What type of report is Purple Biotech Ltd. filing?
Purple Biotech Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
When was the Annual General Meeting of Shareholders held?
The Annual General Meeting of Shareholders was held on April 22, 2025.
Where did the Annual General Meeting of Shareholders take place?
The meeting took place at the Company's offices in Rehovot, Israel.
Does Purple Biotech Ltd. file annual reports under Form 20-F or Form 40-F?
Purple Biotech Ltd. files annual reports under Form 20-F.
What was the former name of Purple Biotech Ltd.?
Purple Biotech Ltd. was formerly known as Kitov Pharma Ltd. and Kitov Pharmaceuticals Holdings Ltd.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 22, 2025 regarding PURPLE BIOTECH LTD. (PPBT).